Lonza Group (LZAGY) Expected to Release Earnings on Wednesday

Lonza Group (OTCMKTS:LZAGY) will likely be posting its resultson Wednesday, July 22nd. Analysts expect Lonza Group to post earnings of $1.09 per share and revenue of $4.2226 billion for the quarter.

Lonza Group Stock Performance

Lonza Group stock opened at $69.28 on Tuesday. The company has a current ratio of 2.24, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Lonza Group has a 12-month low of $58.53 and a 12-month high of $73.85. The business’s 50-day moving average price is $65.03 and its two-hundred day moving average price is $65.62.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Lonza Group from a “strong sell” rating to a “hold” rating in a research note on Wednesday, April 8th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Lonza Group has an average rating of “Moderate Buy”.

About Lonza Group

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.